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Background: Although it has recently been recognised that inflammation is important in the development of
work-related musculoskeletal disorders (MSDs), the exact pathophysiological pathways are unknown.
Methods: We investigated serum concentrations of inflammatory cytokines in 35 female supermarket cashiers with
repetitive work tasks and work related neck/shoulder complaints, compared with those from 25 women without
MSDs (6 supermarket cashiers and 19 middle-school teachers or faculty staff). None of the subjects were pregnant
or lactating, and showed no signs of rheumatoid arthritis, systemic lupus erythematosus, cancer, diabetes, coronary
artery disease or inadequately controlled hypertension. Serum levels of IL-1α, IL-1β, IL-6, IL-8, IL-10, IL-12, MCP-1,
MIP-1α, MIP-1β, TNF-α, GM-CSF, CTGF and CRP were analysed.
Results: The women with pain related to MSD had higher serum concentrations of MIP-1β (median, 25th-75th
percentile: 90.0 pg/mL, 62.5-110 vs. 73.1 pg/mL, 54.6-88.3; p = 0.018), IL-12 (0.26 pg/mL, 0.26-0.26 vs. 0.26 pg/mL,
0.26-0.26; p = 0.047) and CRP (0.5 mg/L, 0.5-1.6 vs. 0.5 mg/L, 0.5-0.5; p = 0.003), than control subjects. Levels of MIP-1α,
MIP-1β and CRP were correlated with the reported intensity of neck/shoulder pain (r = 0.29, p = 0.03 for MIP-1α;
r = 0.29, p = 0.02 for MIP-1β and r = 0.43, p = 0.001 for CRP). No statistically significant differences in serum levels were
found for the remaining cytokines.
Conclusions: Otherwise healthy females with ongoing work-related neck/shoulder pain showed higher serum
concentrations of MIP-1β, IL-12 and CRP than controls, and the levels of MIP-1α, MIP-1β and CRP were correlated to
pain intensity. These results support previous findings that inflammatory processes play a part in work related MSDs.
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Work-related musculoskeletal disorders (MSDs) are a
widespread public health problem. However, the exact
pathophysiological pathways of these disorders are still
unknown. It is therefore important to study possible
mechanisms, to enable the early identification of those
at risk of developing MSDs as a result of different types
of exposures, and to allow appropriate therapeutic
interventions.
The role of inflammation in the early phases of MSDs
has been highlighted in many recent publications [1,2].
Several animal studies have shown inflammatory changes* Correspondence: catarina.nordander@med.lu.se
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distribution, and reproduction in any mediumin tissues following repetitive tasks. Soslowsky et al. [3]
reported continuous deterioration of the mechanical prop-
erties of a tendon, induced by overuse for 16 weeks. Histo-
logical examination revealed increased cellularity and
increased cross-sectional area of the tendon, indicating in-
flammation. Signs of widespread inflammation have also
been found in the tissues and in serum of animals per-
forming repetitive tasks. Barbe et al. [4] constructed an
animal model in which rats were trained to reach repeat-
edly for food pellets, or to reach and pull a handle for a
food reward [2,5]. Although this was a low-intensity task,
increasing numbers of infiltrating macrophages were seen
in all four limbs after one month of performing the task,
indicating inflammation on a systemic level. A significant
increase in resident macrophages in the limb used ford Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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cytokine IL-1α were found after eight weeks. Barbe et al.
therefore suggested that musculotendinous injuries result-
ing from performing repetitive, and/or forceful, tasks lead
to an early inflammatory response. In a more recent study
of humans, Carp et al. [6] found a correlation between the
severity of newly developed upper extremity overuse MSD
in patients and serum levels of inflammatory cytokines
and C-reactive protein (CRP), thus also supporting the
role of an early inflammatory response in the development
of overuse MSD. If the loads are low, or sufficient time is
allowed, complete recovery from inflammation may be
possible. However, if tissue repair cannot take place due to
continued demands on injured and inflamed tissues, a
chronic inflammatory process may result [1,7,8].
If systemic inflammatory processes do indeed play an
important role in the development of overuse injuries, it
may be possible to assess work-related MSDs using bio-
markers of inflammation. Such biomarkers provide ob-
jective measures of pathophysiological processes, and
studies in humans at different stages of disease progres-
sion could provide valuable information. The aim of the
present study was, thus, to investigate whether levels of
biomarkers of inflammation were higher in workers with
work-related MSDs, recruited from the working popula-
tion, and not from a health-care provider, than in fe-
males not reporting any MSDs. In addition, since
previous studies have shown an increased number of
macrophages in tissues of animals performing repetitive
tasks [4,9], cytokines known to be associated with mac-
rophages were also analysed.
Methods
Study design
Subjects were recruited from two ongoing epidemio-
logical studies (Balogh et al. to be published, Arvidsson
et al. to be published), in which postal questionnaires re-
garding the frequency and intensity of musculoskeletal
symptoms [10], as well as whether the symptoms were
perceived as work-related, were sent out. Female super-
market cashiers with and without ongoing work-related
neck and/or shoulder pain were identified, as were fe-
male teachers without such complaints. Cashiers are of
special interest since they are exposed to repetitive
reaching and grasping during a substantial part of the
working day. Teaching, on the other hand, is essentially
a varied, mobile form of work. To ensure a sufficiently
large control group, faculty and staff from our depart-
ment, all performing varied work tasks, were also in-
cluded. Eligible subjects received a letter containing
information about the study and were thereafter contacted
by telephone. Those who were willing to participate in the
study were interviewed regarding their medical health
status, using a standardized questionnaire. A final painassessment, and blood sampling, were performed at our
clinic.
The study was approved by the Regional Ethical Review
Board in Lund. All subjects signed an informed consent
form, after receiving written and oral information.
Pain assessment
For MSD subjects inclusion criteria were pain or dis-
comfort in the neck and/or shoulders since at least one
month, as reported in the questionnaire. The intensity of
pain was required to be at least 3 on a Borg scale be-
tween 0 and 10 [11,12]. During the past 12 months, the
subject was required to have experienced this pain
“often” or “very often” on a 5-point scale ranging from
“never”, “seldom”, “sometimes”, “often” to “very often”
[13]. The problems were also to be perceived by the sub-
ject as work related. On the day of blood sampling, the
intensity of pain was required to be at least 3.
Immediately following blood sampling, all participants
were interviewed regarding musculoskeletal symptoms
in the neck, shoulders, elbows and hands, upper and
lower back, hips, knees and feet, providing data on pain
or discomfort in 9 different regions of the body. The
MSD subjects were once again asked to estimate the
intensity of pain in their neck and shoulders, using the
11-point Borg scale. An average neck and shoulder pain
intensity was calculated from the reported intensities in
these regions. A standardized physical examination of
the neck, shoulders, elbows and hands was also per-
formed in and diagnoses were made according to prede-
fined criteria [14,15].
Blood samples were collected from the individuals in
the control group, provided that they had reported pain
or discomfort from any site in the musculoskeletal sys-
tem no more than “sometimes” during the past 12-
months, and did not report any musculoskeletal pain at
all on the day of the blood sampling.
Subjects
Exclusion criteria were known rheumatoid arthritis or
systemic lupus erythematosus. Subjects with cancer, dia-
betes, coronary artery disease or inadequately controlled
hypertension were also excluded, as were women who
were pregnant or lactating. The body mass index (BMI)
was required to be between 18 and 30. Subjects were ex-
cluded if they were currently taking medication containing
cortisone. Subjects taking non-steroidal anti-inflammatory
drugs (NSAIDs) were included only if they could refrain
from taking these medications for 7 days prior to the
blood test. Similarly subjects using tobacco products were
excluded unless they could refrain from using such prod-
ucts 7 days prior to the blood test. Subjects who had had a
cold or any other infection during the 7 days prior to the
blood test were asked to come back at a later date. On the
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ples were also taken to determine thyroid function and
rheumatoid factor (RF). Subjects showing abnormalities
regarding these parameters were excluded.
Fifty-one subjects with work-related neck and/or
shoulder pain were recruited for blood sampling. Of
these, one subject who tested positive for RF and one
subject found to have thyroid dysregulation were ex-
cluded. Fourteen subjects did not report neck and/or
shoulder pain of at least moderate intensity, and were
therefore excluded, leaving a group of 35 subjects.
Thirty-six symptom-free control subjects were re-
cruited. Of these, 11 reported temporary pain on the day
of blood sampling and were excluded, leaving 25 control
subjects in the group. Of the control subjects 6 were ca-
shiers and 19 were middle-school teachers or faculty and
staff at our department, with non-repetitive work tasks.
The mean BMI was 24 kg/m2 (SD 3) in the MSD sub-
jects, and in the control group 23 kg/m2 (SD 2). BMIs
were evenly distributed between subjects with different
work tasks in the control group. The mean age was
45 years (SD 14) in the MSD group and 42 (SD 10) in
the control group, also evenly distributed between sub-
jects with different work tasks.
Serum samples and analyses
All serum samples were collected prior to the physical
examination, between 10 am and 12 noon. Samples were
either sent to the laboratory at the Department of Clin-
ical Chemistry at the Skåne University Hospital for im-
mediate analysis or stored at -80°C until analysis. Serum
samples for the analysis of thyroid function (thyroid
stimulating hormone and thyroxine) as well as RF and
C-reactive protein (CRP) were sent continuously to the
laboratory at the Department of Clinical Chemistry, and
analysed according to standard procedures.
Cytokine serum levels of 6 interleukins [IL-1α, IL-1β,
IL-6, IL-8, IL-10, IL-12 (p70)], monocyte chemotactic
protein 1 (MCP-1), macrophage inflammatory protein
1α (MIP-1α), MIP-1β, granulocyte-macrophage colony-
stimulating factor (GM-CSF) and tumour necrosis factor
α (TNF-α) were determined using multiplex immuno-
assay analysis, on a Bio-Plex 200 Luminex instrument
(Bio-Rad, Hercules, CA, USA). Triplicate analyses were
performed on each sample. Single-plex magnetic bead-
based assays (Bio-Rad) containing beads coated with
antibodies specific for each analyte were mixed, and the
assay was performed according to the instructions of the
manufacturer’s instructions, with some minor changes.
The time for incubation between beads and sample was
increased to 60 minutes. All wash steps were performed
using a Bio-Plex Pro wash-station (Bio-Rad). Standard
curve and concentrations of cytokines were determined
by Bio-Plex Manager 6.0 software (Bio-Rad) using five-parameter curve fitting. The lower limit of detection
(LOD) was determined as the mean value of the concen-
tration of the lowest detectable standard identified
within each analysis. The LODs for the measured cyto-
kines were (pg/mL): IL-1α, 0.30; IL-1β, 0.52; IL-6, 0.30;
IL-8, 0.41; IL-10, 0.43; IL-12, 0.51; TNF-α, 1.2; MIP-1α,
0.32; MIP-1β, 0.86; MCP-1, 0.36; GM-CSF, 0.85.
The levels of a few some of the cytokines were very
low, partly due to dilution of the samples (performed ac-
cording to the instructions of the protocol), and values
were extrapolated (flagged by the software) below the
lowest standard point. After multiplying by four, to cal-
culate the true concentration, most values were above
the detection limit. Concentrations that were still below
the LOD were assigned a value of half the LOD. The
lower detection level of CRP was 1.0 mg/L, and values
below this were set to 0.5 mg/L.
Connective tissue growth factor (CTGF) was analysed
using a commercially available ELISA kit from Adipo
Bioscience (Santa Clara, CA, USA). Serum samples were
analysed in duplicate according to the manufacturer’s
instructions.Statistical analysis
All statistical analyses were conducted in SPSS 18.0
(SPSS, Chicago, IL, USA). A p-value of less than 0.05
(two-tailed) was accepted as a statistically significant dif-
ference. Since the data were skewed, comparisons be-
tween group means were performed using independent
samples t-tests with values transformed according to the
natural logarithm, giving normally distributed data. To
investigate the effects of possible confounders ANOVA
analysis was applied for the covariates BMI and age.
Correlations were tested using Spearman’s test.Results
All the cytokines except IL-1α and GM-CSF could be
detected in the serum of the majority of the subjects.
When analysing the cytokines we found correlations be-
tween TNF-α and the interleukins IL-1β, IL-6 and IL-10
(Table 1). Correlations were also found between the in-
terleukins themselves, although these were not as strong.
MIP-1β was weakly correlated with TNF α, IL-1β and
IL-6. MIP-1α showed a statistically significant correl-
ation to IL-12.
The results obtained from the serum analyses are sum-
marized in Table 2. A statistically significant increase in
serum concentration of IL-12, MIP-1β and CRP was
found in the MSD group compared to the control group.
Furthermore, the concentrations of all the cytokines ex-
cept MCP-1, TNF-α and CTGF were higher in the MSD
group than in the control group, although these differ-
ences were not statistically significant.
Table 1 Correlation matrix (Spearman rank-correlation coefficients; rs) for cytokine and CRP levels
IL-6 IL-8 IL-10 IL-12 MCP-1 MIP-1α MIP-1β TNF-α CTGF CRP1
IL-1β rs .34** .04 .57** .07 .01 .13 .31* .70** .05 .01
IL-6 rs -.08 .34** -.12 .10 -.07 .16 .62** -.21 .08
IL-8 rs .12 -.13 .36** .12 .34** .03 -.28* .01
IL-10 rs .01 .05 .02 .24 .61** -.04 -.15
IL-12 rs -.03 .44** .09 -.03 .09 -.19
MCP-1 rs -.11 .05 .10 -.17 .12
MIP-1α rs .16 .01 -.11 .12
MIP-1β rs .33** -.15 .01
TNF-α rs -.12 -.18
CTGF rs -.14
Results in bold face are statistically significant.
1CRP value from one individual is missing due to technical errors.
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mediators when the control subjects were divided into
two groups according to their working conditions, form-
ing one group withvaried and non-repetitive work tasks
(teachers and faculty and staff at our department), and
another with repetitive work tasks (cashiers). When
comparing the affected cashiers with the control subjects
with non-repetitive work tasks, the former still showed
higher levels of IL-12 (p = 0.047), MIP-1β (p = 0.04) and
CRP (p = 0.002). The number of unaffected cashiers was
too small to allow statistical testing.
In the MSD group the median of the self-reported pain
intensity from the neck and shoulder region was 4.5 (25th-
75th percentile 3.0-6.0) and the median duration of pain
from this region was 72 months (36-120). The median
number of diagnoses was 1.0 (0-2.5) in the neck andTable 2 Cytokine¹ (in pg/mL) and CRP (in mg/L) levels in subjec
controls, given as median, 25th and 75th percentile
Subjects with MSD (N=35) Controls
IL-1β 0.58 (0.26-0.90) 0.53 (0.26-
IL-6 0.82 (0.15-1.8) 0.50 (0.15-
IL-8 5.7 (3.8-8.1) 5.3 (3.9-7.0
IL-10 1.0 (0.84-2.4) 0.93 (0.76-
IL-12 0.26 (0.26-0.26) 0.26 (0.26-
MCP-1 27 (20-40) 29 (22-38)
MIP-1α 0.16 (0.16-2.2) 0.16 (0.16-
MIP-1β 90 (63-110) 73 (55-88)
TNF-α 3.1 (1.8-5.1) 3.2 (2.4-3.8
CTGF 244 (67-420) 67 (67-350
CRP4 0.50 (0.50-1.6) 0.50 (0.50-
P-values from T-tests2.
Results in bold face are statistically significant.
1IL-1α and GM-CSF were not detectable in the serum of any subject and are therefo
2p-values calculated using values transformed according to the natural logarithm.
3Adjusted for age and BMI.
4CRP value from one individual is missing due to technical errors.shoulder region and 1.0 (0-3.0) in the neck/shoulder and
elbow/hand region combined. The most frequent diagno-
ses were rotator cuff tendonitis, acromioclavicular joint
syndrome and tension neck syndrome. A statistically sig-
nificant positive correlation was found between pain
intensity in the neck/shoulders and three cytokines: MIP-
1α, MIP-1β and CRP (Figure 1). The correlation coeffi-
cients (rs) were 0.29 (p = 0.03), 0.29 (p = 0.02) and 0.43
(p = 0.001) for MIP-1 α, MIP-1β and CRP, respectively.
The median number of affected body regions in the
MSD subjects, of the 9 regions from which data were
collected, was 4.0 (2.0 – 5.0). CRP concentration was
correlated with the total number of affected body re-
gions (rs = 0.45, p < 0.001).
No other cytokines showed correlations with pain in-
tensity or the number of body regions affected. CRPts with work-related musculoskeletal disorder (MSD) and












re not shown in the table.
Figure 1 Correlation between CRP and average neck/shoulder
pain intensity. Spearman’s rank correlation coefficient (rs) = 0.43;
p = 0.001. Markers of subjects with the same value on both axes
have been scattered around the true value, for the sake of clarity.
The CRP concentration is missing for one individual due to a
technical error. Open circles denote subjects with work-related MSD
(affected), and filled diamonds denote control subjects (unaffected).
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0.48, p < 0.001). However, we found no correlations be-
tween the cytokine levels and age or BMI. BMI was
weakly correlated with pain intensity (p = 0.10) and the
number of affected body regions (p = 0.06). Adjustment
for BMI and age did not significantly affect the results
(Table 2).
Discussion
We found increased levels of IL-12, MIP-1β and CRP in
the serum of subjects with work related MSD in the
neck/shoulder region. We believe these findings repre-
sent an ongoing inflammation in these individuals.
Methodological considerations
As there was a time delay between answering the initial
postal questionnaire and blood sampling in some cases,
all subjects were interviewed regarding their current
health status on the day of the blood test, and only sub-
jects who were affected or unaffected, at the time of an-
swering the questionnaire and on the day of the blood
test, were included in the study. All calculations were
performed on the results obtained from the interview
and examination on the day of the blood test. In this
way we were able form clearly distinct groups of subjects
with and without MSDs.The serum used for analysing the cytokines was frozen
immediately after sampling. Since the recruiting of suit-
able subjects was a lengthy process, some samples were
stored in the freezer for up to three years. When analys-
ing the samples, we therefore paid special attention to
any signs of possible drift in concentrations in the older
samples. However, we observed no such drift, and there-
fore believe that the storage time did not affect the qual-
ity of the samples or the results obtained. Blood tests for
CRP, on the other hand, were analysed continuously at
the laboratory of the Skåne University Hospital. This re-
sulted in a relatively crude analysis for our purpose. In
spite of this, we found a statistically significant elevation
of CRP levels in the MSD group and a correlation be-
tween CRP and pain intensity.
The age distributions in the affected and unaffected
groups were comparable, and we found no correlations
between age and any of the cytokines analysed or CRP.
Age has, however, been suggested to correlate with in-
flammatory status [16], and we therefore adjusted for this
variable. Doing so did not significantly change the results.
Increased BMI is known to be associated with elevated
CRP levels [17], and obesity has also been reported to
affect cytokine levels [18] and, therefore, only subjects
with BMI in the range 18-30 were included in the study.
We found no correlations between the cytokines and
BMI but, as would be expected, we did find a correlation
between BMI and CRP. The two groups were, however,
very similar with regard to BMI, and adjusting for BMI
in a statistical model did not affect the result.
CRP is a marker of any type of inflammatory process,
and there may be many reasons for an increase in CRP
levels in an individual. Individuals with colds or other
infections were, however, asked to return for blood sam-
pling and examination at a later date. Our exclusion cri-
teria also contained several disorders associated with
inflammation. Thus, we believe that the elevated CRP
levels found in the MSD group did in fact reflect an in-
flammatory component of their MSD.
IL-12 is released from classically activated macro-
phages following activation signals via e.g. TNF-α and
GM-CSF [19]. IL-12 levels were generally low in this
study, and only four subjects had levels above the LOD.
However, all of these were MSD subjects and we there-
fore observed a statistically significant difference be-
tween groups with and without MSDs. This finding is
interesting, but it is not possible to draw any conclusions
with such a limited number of samples above the LOD.
Performing multiple analyses may increase the risk of
discovering seemingly significant findings by chance.
This is a limitation of the study, but the observed in-
creases in CRP and MIP-1β are in line with previously
published results, and can be explained from a patho-
physiological perspective.
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found to be correlated with each other. This is consist-
ent with the belief that inflammatory cytokines can
stimulate the production of one another. For example,
IL-1α and TNF-α have been shown to induce cytokine
gene expression and production [20].
Implications
We were not able to verify the results of previous stud-
ies, in which the pro-inflammatory cytokines IL-1 or
TNF-α were found to be elevated in animals and pa-
tients suffering from MSD caused by repetitive stress
[1,4,6]. In these studies, relatively newly developed disor-
ders were examined, whereas our subjects had a long
history of overuse MSD. However, increases were ob-
served in pro-inflammatory chemokines (small cytokines),
as discussed below.
Since previous studies have shown an increase in mac-
rophages in the tissues, as well as an increase in the
macrophage inflammatory protein 3a in serum, in ani-
mals performing repetitive tasks [5], we included cyto-
kines associated with macrophages in our analyses. The
results showed a statistically significant increase in MIP-
1β, a cytokine released by neutrophils, which acts as a
chemokine and activating factor for monocytes and mac-
rophages [21]. This finding is consistent with the find-
ings of Barbe et al. [4]. Interestingly, MIP-1β was also
correlated with the reported intensity of pain in the neck
and shoulder in our subjects, suggesting that the level of
MIP-1β increases with the severity of the disorder. To
the best of our knowledge, MIP-1β has not previously
been evaluated in subjects with overuse MSD. MIP-1α
was also correlated to pain intensity, and showed a ten-
dency towards elevated serum levels in the MSD group.
However, this elevation was not statistically significant.
CRP is a well-known and reliable biomarker of inflam-
mation and tissue injury [17], and it has also been found
to be elevated in subjects with repetitive work tasks [22]
and MSD [6]. We found increased CRP levels in a sub-
stantial proportion (48%) of the affected subjects, indi-
cating an underlying systemic inflammatory process in
these individuals. Like MIP-1α and MIP-1β, CRP was
correlated to the severity of neck/shoulder symptoms,
but interestingly, MIP-1α, MIP-1β and CRP were not
correlated with each other. It is possible that these bio-
markers reflect different stages of an inflammatory
process. The MSD subjects had both a long history of
pain and a continuing exposure to repetitive work tasks.
It could, therefore, be expected that we would find dif-
ferent stages of the inflammatory process within this
group, and perhaps even within the same individual.
It has been suggested that repetitive and force demand-
ing tasks lead to tissue fatigue failure [7,8], initially with
inflammatory processes, followed by fibrotic processes.CTGF has been suggested as a potential mediator of fi-
brotic events [23,24], and has been shown to increase in
the later stages of work-related MSDs [25,26]. Elevated
levels of MIPs and CRP, but no difference concerning
CTGF, between the subjects with and without MSD in the
present study, may thus indicate that the affected subjects
were in an inflammatory phase.
Since no differences were seen in cytokine levels be-
tween the control subjects with and without repetitive
work tasks, we believe that the observed increase in in-
flammatory mediators seen in the MSD group is due to
the musculoskeletal disorder resulting in pain, and not
to the repetitive work itself.Conclusions
Signs of inflammation could be found in our subjects,
despite the fact that they were recruited from the work-
ing population, and not from a health-care provider. We
believe this is an important field for future research,
since discovering the underlying pathophysiological
mechanisms causing work-related MSD provide oppor-
tunities to assess, treat and prevent these disorders.
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